Here we demonstrated that IFN-γ treatment affected the expression of p21 in both of normal melanocytes and vitiligo melanocytes without changing the protein levels of p53 and p16, and only knocking-down of p21 was effective to prevent the IFN-γ-induced melanocyte senescence. The gene discussed is TP53; the disease is vitiligo.